248 related articles for article (PubMed ID: 29710517)
21. Transcriptome-wide analysis of alternative RNA splicing events in Epstein-Barr virus-associated gastric carcinomas.
Armero VES; Tremblay MP; Allaire A; Boudreault S; Martenon-Brodeur C; Duval C; Durand M; Lapointe E; Thibault P; Tremblay-Létourneau M; Perreault JP; Scott MS; Bisaillon M
PLoS One; 2017; 12(5):e0176880. PubMed ID: 28493890
[TBL] [Abstract][Full Text] [Related]
22. Baicalein targets STMN1 to inhibit the progression of nasopharyngeal carcinoma via regulating the Wnt/β-catenin pathway.
Li Z; Cai X
Environ Toxicol; 2024 May; 39(5):3003-3013. PubMed ID: 38317500
[TBL] [Abstract][Full Text] [Related]
23. Progesterone analogues reduce plasma Epstein-Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care.
Hung CY; Lin TL; Kuo YC; Hsieh CH; Wang HM; Hsu CL
Biomed J; 2017 Aug; 40(4):212-218. PubMed ID: 28918909
[TBL] [Abstract][Full Text] [Related]
24. Regulation of EBNA1 protein stability and DNA replication activity by PLOD1 lysine hydroxylase.
Dheekollu J; Wiedmer A; Soldan SS; Castro-Muñoz LJ; Chen C; Tang HY; Speicher DW; Lieberman PM
PLoS Pathog; 2023 Jun; 19(6):e1010478. PubMed ID: 37262099
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
[TBL] [Abstract][Full Text] [Related]
26. Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker.
Dochi H; Kondo S; Komura S; Moriyama-Kita M; Komori T; Nanbo A; Sakaguchi M; Fukuyo M; Hamabe-Horiike T; Tanaka M; Mizokami H; Kano M; Kitagawa Y; Kobayashi E; Hirai N; Ueno T; Nakanishi Y; Endo K; Sugimoto H; Hanayama R; Kaneda A; Yoshizaki T
Int J Cancer; 2024 Mar; 154(5):895-911. PubMed ID: 37907830
[TBL] [Abstract][Full Text] [Related]
27. The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold.
Humme S; Reisbach G; Feederle R; Delecluse HJ; Bousset K; Hammerschmidt W; Schepers A
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10989-94. PubMed ID: 12947043
[TBL] [Abstract][Full Text] [Related]
28. Development and analytical validation of a novel nasopharynx swab-based Epstein-Barr virus C promoter methylation quantitative assay for nasopharyngeal carcinoma detection.
Wu ZC; Lin KN; Li XQ; Ye X; Chen H; Tao J; Zhou HN; Chen WJ; Lin DF; Xie SH; Cao SM
Clin Chem Lab Med; 2024 Jan; 62(1):187-198. PubMed ID: 37531579
[TBL] [Abstract][Full Text] [Related]
29. Establishment and Characterization of an Epstein-Barr Virus-positive Cell Line from a Non-keratinizing Differentiated Primary Nasopharyngeal Carcinoma.
Chai AWY; Yee SM; Lee HM; Abdul Aziz N; Yee PS; Marzuki M; Wong KW; Chiang AKS; Chow LK; Dai W; Liu TF; Tan LP; Khoo ASB; Lo KW; Lim PVH; Rajadurai P; Lightfoot H; Barthorpe S; Garnett MJ; Cheong SC
Cancer Res Commun; 2024 Mar; 4(3):645-659. PubMed ID: 38358347
[TBL] [Abstract][Full Text] [Related]
30. Alterations in cellular expression in EBV infected epithelial cell lines and tumors.
Edwards RH; Dekroon R; Raab-Traub N
PLoS Pathog; 2019 Oct; 15(10):e1008071. PubMed ID: 31584998
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent antigens EBNA3C and EBNA1 modulate epithelial to mesenchymal transition of cancer cells associated with tumor metastasis.
Gaur N; Gandhi J; Robertson ES; Verma SC; Kaul R
Tumour Biol; 2015 Apr; 36(4):3051-60. PubMed ID: 25501510
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.
Koon HK; Lo KW; Leung KN; Lung ML; Chang CC; Wong RN; Leung WN; Mak NK
Cell Mol Immunol; 2010 Jul; 7(4):323-6. PubMed ID: 20228836
[TBL] [Abstract][Full Text] [Related]
33. Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.
Murakami M; Kaul R; Kumar P; Robertson ES
Mol Cell Biochem; 2009 Sep; 329(1-2):131-9. PubMed ID: 19412732
[TBL] [Abstract][Full Text] [Related]
34. Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells.
Caves EA; Cook SA; Lee N; Stoltz D; Watkins S; Shair KHY
mSphere; 2018 Jul; 3(4):. PubMed ID: 30021875
[TBL] [Abstract][Full Text] [Related]
35. mRNA-based Vaccines Targeting the T-cell Epitope-rich Domain of Epstein Barr Virus Latent Proteins Elicit Robust Anti-Tumor Immunity in Mice.
Zhao GX; Bu GL; Liu GF; Kong XW; Sun C; Li ZQ; Dai DL; Sun HX; Kang YF; Feng GK; Zhong Q; Zeng MS
Adv Sci (Weinh); 2023 Dec; 10(35):e2302116. PubMed ID: 37890462
[TBL] [Abstract][Full Text] [Related]
36. Association between Epstein-Barr virus infection and chemoresistance to docetaxel in gastric carcinoma.
Shin HJ; Kim DN; Lee SK
Mol Cells; 2011 Aug; 32(2):173-9. PubMed ID: 21626300
[TBL] [Abstract][Full Text] [Related]
37. Detection of Human Papillomavirus Genotypes and Epstein-Barr Virus in Nasopharyngeal Carcinomas at the Korle-Bu Teaching Hospital, Ghana.
Asante DB; Asmah RH; Adjei AA; Kyei F; Simpong DL; Brown CA; Gyasi RK
ScientificWorldJournal; 2017; 2017():2721367. PubMed ID: 28421207
[TBL] [Abstract][Full Text] [Related]
38. EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes.
Kapoor P; Frappier L
J Virol; 2003 Jun; 77(12):6946-56. PubMed ID: 12768013
[TBL] [Abstract][Full Text] [Related]
39. EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls.
Monaco MCG; Soldan SS; Su C; Clauze A; Cooper JF; Patel RJ; Lu F; Hughes RJ; Messick TE; Andrada FC; Ohayon J; Lieberman PM; Jacobson S
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37562974
[TBL] [Abstract][Full Text] [Related]
40. EBV abortive lytic cycle promotes nasopharyngeal carcinoma progression through recruiting monocytes and regulating their directed differentiation.
Xu X; Zhu N; Zheng J; Peng Y; Zeng MS; Deng K; Duan C; Yuan Y
PLoS Pathog; 2024 Jan; 20(1):e1011934. PubMed ID: 38206974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
